About the company
Eli Lilly and Company, commonly known as Lilly, is a global pharmaceutical company with a rich history of more than 140 years. Founded by Colonel Eli Lilly in 1876, the company has become a leader in the healthcare industry, dedicating its efforts and resources to develop innovative treatments to improve the lives of patients around the world. Lilly's focus on neuroscience underscores its commitment to finding solutions for some of the most complex and challenging diseases affecting the brain and nervous system. Through extensive research, Lilly aims to uncover new therapies to address conditions such as Alzheimer's disease, Parkinson's disease, migraine, depression, and schizophrenia. The company recognizes the immense burden that mental health disorders place on both patients and their families, and thus strives to provide effective treatment options that can enhance cognitive function, alleviate symptoms, and ultimately improve overall quality of life. In the realm of cardiometabolic disorders, Lilly has developed groundbreaking medications to treat conditions such as diabetes and cardiovascular diseases. One of their notable products, Jardiance, has been shown to dramatically reduce the risk of cardiovascular death in patients with type 2 diabetes mellitus. Additionally, Trulicity, a once-weekly injectable medication, has proven to be highly effective in managing blood sugar levels and reducing the risk of major adverse cardiovascular events. These medications exemplify Lilly's commitment to advancing treatments that not only address the symptoms but also target the underlying causes of cardiometabolic disorders. Lilly's dedication to oncology is evident through the development of Verzenio, a targeted therapy for breast cancer. Verzenio has shown promising results in extending survival and improving quality of life for patients battling advanced or metastatic breast cancer. The company is also involved in the exploration of other cancer treatments, with ongoing research and development efforts aimed at identifying innovative therapies for a wide range of malignancies. By collaborating with renowned oncology centers and experts worldwide, Lilly aims to contribute to significant advancements in cancer care. In the field of immunology, Lilly has made significant strides in developing medications for autoimmune diseases. Their product Taltz, for example, is used to treat conditions such as psoriasis, psoriatic arthritis, and ankylosing spondylitis. Taltz targets specific proteins involved in the body's immune response, effectively reducing inflammation and providing relief to patients suffering from these debilitating diseases. Another immunology product, Olumiant, has shown efficacy in the treatment of rheumatoid arthritis by inhibiting the activity of enzymes responsible for promoting inflammation within the joints. With a strong focus on research and development, Lilly continuously seeks to identify unmet medical needs and explore new therapeutic avenues. This commitment can be witnessed through their extensive clinical trials and collaborations with academic institutions, government agencies, and other pharmaceutical companies. By constantly pushing the boundaries of science and technology, Lilly aims to unlock potential breakthroughs in medicine that can revolutionize patient care and contribute to the advancement of global health. Overall, Eli Lilly's dedication to the areas of neuroscience, cardiometabolic disorders, oncology, and immunology demonstrates their steadfast commitment to improving the well-being of individuals worldwide. As a leading pharmaceutical company, Lilly strives to develop innovative treatments that address the most pressing medical challenges of our time. Through their cutting-edge research and collaborative efforts, they continue to make significant contributions to the field of healthcare, ultimately aiming to provide hope and restore health to patients in need.
Website: https://www.lilly.com
Data updated: June 2, 2026
